PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-04-21
DOI
10.3389/fonc.2023.1167930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastatic uveal melanoma: The final frontier
- (2022) Elina S. Rantala et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma
- (2022) Zhenghang Wang et al. BMC Medicine
- PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma
- (2022) Zhihuai Wang et al. DISEASE MARKERS
- Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
- (2021) Constantin Stefani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
- (2021) Le Yu et al. SEMINARS IN CANCER BIOLOGY
- Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
- (2021) Nazanin Momeni Roudsari et al. Pharmaceutics
- Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
- (2021) Maryam Akbarzadeh et al. LIFE SCIENCES
- Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway
- (2021) Mohd Farhan et al. Oxidative Medicine and Cellular Longevity
- Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
- (2021) Zaoqu Liu et al. EBioMedicine
- The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
- (2020) Ina Nepstad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pyrroloquinoline Quinine and LY294002 Changed Cell Cycle and Apoptosis by Regulating PI3K-AKT-GSK3β Pathway in SH-SY5Y Cells
- (2020) Hongyun Ji et al. NEUROTOXICITY RESEARCH
- Uveal melanoma pathobiology: metastasis to the liver
- (2020) Prisca Bustamante et al. SEMINARS IN CANCER BIOLOGY
- The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
- (2020) Boris Y. Shorning et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
- (2020) Sadegh Fattahi et al. LIFE SCIENCES
- PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
- (2019) Alia Ghoneum et al. Cancers
- Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors
- (2019) Ying Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
- (2018) Francesca Corti et al. CANCER TREATMENT REVIEWS
- Recent advances in uveal melanoma treatment
- (2017) Beatriz Álvarez-Rodríguez et al. MEDICINAL RESEARCH REVIEWS
- Disparities in Uveal Melanoma: Patient Characteristics
- (2016) Erin E. Nichols et al. Seminars in Ophthalmology
- The effect and underlying mechanism of Timosaponin B-II on RGC-5 necroptosis induced by hydrogen peroxide
- (2014) San-Hong Jiang et al. BMC Complementary and Alternative Medicine
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway
- (2012) Sang-Won Hong et al. CANCER SCIENCE
- Uveal melanoma
- (2012) Francesco Spagnolo et al. CANCER TREATMENT REVIEWS
- Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
- (2012) Vassiliki Papadimitrakopoulou Journal of Thoracic Oncology
- The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
- (2008) T Weichhart et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started